Y-Intercept (Hong Kong) Ltd
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1772875
HONG KONG, K3
Position in XERS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$3,257,860
+$2,319,461 QoQ
Shares Held
411,346
+154.2% QoQ
Ownership
0.238%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1
of 7 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $54,645,005 across 16 Drug Manufacturers - Specialty & Generic names. XERS ranks #7 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
147,055 | $10,567,372 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
14,271 | $7,732,455 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
190,145 | $6,592,327 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
136,725 | $5,609,826 | |
| 5 | VTRS |
Viatris Inc
|
331,130 | $5,258,344 | |
| 6 | PRGO |
PERRIGO Co plc
|
346,586 | $3,601,028 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
411,346 | $3,257,860 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
34,505 | $2,856,323 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,257,860 | 411,346 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $938,399 | 161,793 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $711,563 | 90,645 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $668,953 | 82,181 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,570,119 | 336,214 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $244,403 | 44,518 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||